Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b study.
Wang F, Chen G, Qiu M, Ma J, Mo X, Liu H, Li Y, Ding P, Wan X, Hu Y, Huang X, Jiang W, Wu X, Luo J, Zhou Y, Li L, Sun Y, Wang Q, Wang N, Jiang W, Yuan W, Li L, Liu L, Yuan X, Wang G, Song Z, Liu H, Ge J, Wang Y, Zhao P, Li T, You J, Tang J, Du X, Lin J, Zhang R, Fu Z, Xu J, Zhong H, Kang L, Deng Y, Lu X, Guo Q, Zhou H, Xu RH.
Wang F, et al. Among authors: liu l.
Cancer Cell. 2025 Oct 13;43(10):1958-1967.e2. doi: 10.1016/j.ccell.2025.09.004. Epub 2025 Oct 2.
Cancer Cell. 2025.
PMID: 41043438
Free article.
Clinical Trial.